Group One Trading
SURF

Group One Trading’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Group One Trading’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,774
Closed -$5.89K – 8584
2023
Q2 		$5.89K Hold
6,774
– – ﹤0.01% 6658
2023
Q1 		$4.73K Sell
6,774
-16,471
-71% -$13.3K ﹤0.01% 6302
2022
Q4 		$19.1K Sell
23,245
-13,374
-37% -$13.2K ﹤0.01% 5630
2022
Q3 		$38K Sell
36,619
-3,117
-8% -$4.98K ﹤0.01% 5625
2022
Q2 		$65K Buy
+39,736
New +$82.5K ﹤0.01% 5348
2021
Q3 		– Sell
-10,217
Closed -$65.4K – 8978
2021
Q2 		$76K Buy
+10,217
New +$78.7K ﹤0.01% 6217
2021
Q1 		– Sell
-13,578
Closed -$136K – 8170
2020
Q4 		$125K Buy
+13,578
New +$118K ﹤0.01% 4402

Group One Trading's SURF Position: Q3 2023 in Review

Group One Trading sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 6,774 shares — an estimated $5.89K sold.

Group One Trading first reported a position in SURF in Q4 2020 and held it in 7 quarters. The position peaked at $125K in Q4 2020. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

  • Group One Trading reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 6,774 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $5.89K.
  • Group One Trading first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Group One Trading's Surface Oncology, Inc. Common Stock position peaked at $125K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.